Interestingly, this improvement of glycemic control was not due to enhanced insulin sensitivity but rather due to improved β-cell secretory function [16] suggesting that IL-1 is more involved in maintaining β-cell homeostasis than in adipose tissue biology in human subjects with type 2 diabetes. This evidence concerns the gene INS and type 2 diabetes mellitus.